BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31463979)

  • 41. [Fetal cardiac defects in pregnancy complicated by diabetes mellitus].
    Mitkowska-Woźniak H; Brazert J
    Ginekol Pol; 2005 Oct; 76(10):828-37. PubMed ID: 16417100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screening.
    Jørgensen DE; Vejlstrup N; Jørgensen C; Maroun LL; Steensberg J; Hessellund A; Jørgensen FS; Larsen T; Shalmi AC; Skibsted L; Zingenberg H; Ekelund C; Tabor A
    Prenat Diagn; 2015 Apr; 35(4):325-30. PubMed ID: 25352400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prenatal diagnosis of congenital heart diseases by fetal echocardiography in second trimester: a Chinese multicenter study.
    Chu C; Yan Y; Ren Y; Li X; Gui Y
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):454-463. PubMed ID: 28029179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accuracy of prenatal diagnosis of congenital heart disease with fetal echocardiography.
    Bakiler AR; Ozer EA; Kanik A; Kanit H; Aktas FN
    Fetal Diagn Ther; 2007; 22(4):241-4. PubMed ID: 17369687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fetal heart scanning in the first trimester.
    Carvalho JS
    Prenat Diagn; 2004 Dec; 24(13):1060-7. PubMed ID: 15614834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early fetal heart ultrasonography as additional indicator for chromosomopathies.
    Dmitrovic A; Jeremic K; Babic UM; Perovic M; Mihailovic T; Opric D; Zecevic N; Gojnić-Dugalić M
    Clin Exp Obstet Gynecol; 2016; 43(2):245-9. PubMed ID: 27132420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for congenital heart disease: a move toward earlier echocardiography.
    Johnson B; Simpson LL
    Am J Perinatol; 2007 Sep; 24(8):449-56. PubMed ID: 17992711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First-trimester fetal heart evaluation: time to move forward.
    Turan S; Goetzinger KR
    Ultrasound Obstet Gynecol; 2021 May; 57(5):677-680. PubMed ID: 33314390
    [No Abstract]   [Full Text] [Related]  

  • 49. Echocardiography in early pregnancy: review of literature.
    Haak MC; van Vugt JM
    J Ultrasound Med; 2003 Mar; 22(3):271-80. PubMed ID: 12636327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First-trimester transabdominal fetal echocardiography.
    Sharland G
    Lancet; 1998 May; 351(9116):1662. PubMed ID: 9620747
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of the fetal heart at 14 to 18 weeks' gestation in fetuses with a screening nuchal translucency greater than or equal to the 95th percentile.
    Foy PM; Wheller JJ; Samuels P; Evans KD
    J Ultrasound Med; 2013 Oct; 32(10):1713-9. PubMed ID: 24065251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance of different scan protocols of fetal echocardiography in the diagnosis of fetal congenital heart disease: a systematic review and meta-analysis.
    Li Y; Hua Y; Fang J; Wang C; Qiao L; Wan C; Mu D; Zhou K
    PLoS One; 2013; 8(6):e65484. PubMed ID: 23750263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fetal echocardiography in diagnosing congenital heart disease prenatally: a multicenter clinical study].
    Zhu RY; Gui YH; Li LC; Chen RY; Sun L; Chang C
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):764-9. PubMed ID: 17229382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of fetal heart anatomy at the end of the first trimester and the beginning of the mid-trimester].
    Szymkiewicz-Dangel J; Hamela-Olkowska A; Strzyzewski W; Lipiński T; Czajkowski K
    Ginekol Pol; 2003 Oct; 74(10):1294-301. PubMed ID: 14669433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal nuchal translucency in severe congenital heart defects: experiences in Northern Finland.
    Alanen J; Leskinen M; Sairanen M; Korpimaki T; Kouru H; Gissler M; Ryynanen M; Nevalainen J
    J Matern Fetal Neonatal Med; 2019 May; 32(9):1454-1460. PubMed ID: 29157037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuchal translucency and fetal cardiac malformations.
    Axt-Fliedner R; Gembruch U
    Ultraschall Med; 2010 Apr; 31(2):144-50. PubMed ID: 20094976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility and accuracy of fetal echocardiography using four-dimensional spatiotemporal image correlation technology before 16 weeks' gestation.
    Bennasar M; Martínez JM; Olivella A; del Río M; Gómez O; Figueras F; Puerto B; Gratacós E
    Ultrasound Obstet Gynecol; 2009 Jun; 33(6):645-51. PubMed ID: 19479815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
    Yang Y; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How successful is fetal echocardiographic examination in the first trimester of pregnancy?
    Haak MC; Twisk JW; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):9-13. PubMed ID: 12100411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
    Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
    Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.